Company Reports >> Medical Devices

 
Single User license
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
$750.00
Site license
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
$1,500.00
Global license
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
$2,250.00
 
Tab
Description
Table of Contents
List of Figures
List of Tables
Request Sample Pages
Send To Friend
Inquire Before Buying

Angioblast Systems, Inc. - Medical Equipment Product Pipeline Analysis

By: Global Markets Direct, Published: Dec-2009    Report Code: GMDME36074PD    Report Format: Electronic PDF

Description


Angioblast Systems, Inc. is a US based biotechnology company. The company is engaged in development and commercialization of therapeutic products for the treatment of cardiovascular diseases. It provides various products which includes adult stem cells, protein therapeutics, gene silencing, small molecule peptides and antibodies, cytokines and antigen-receptor inhibitors, and DNAzymes. It also offers the MPC products for heart failure, heart attacks, peripheral artery diseases, and wound ulcers. The company has a strategic alliance with Mesoblast Limited. The company forms the relationships with diverse corporate partners to enable rapid penetration in each market by product and geography.

This report is an insightful source for data, analysis and strategic insights into Angioblast Systems, Inc.’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Provides key company information for business intelligence needs.
  • Details of the company’s products by development stage.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials for the company’s products covering trial phase, description, investigator information, primary and secondary end-points and trial results.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications by the company relating to its product pipeline.
  • News updates on key events relating to the company’s products and their development.

Reasons to Buy

  • A quick “one-stop-shop” to understand the company.
  • Identify competitor’s pipeline products.
  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and Research and Development initiatives based on regulatory events of competitor product pipelines.
  • Identify potential investment opportunities.
  • Avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.
  • Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities